{
    "id": 23152,
    "fullName": "ATF7IP - JAK2",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "ATF7IP-JAK2 results from the fusion of ATF7IP and JAK2 (PMID: 25207766). ATF7IP-JAK2 is predicted to result in a gain of fusion protein function, due to sensitivity to Jak2 inhibition in cultured cells (PMID: 25207766).",
            "references": [
                {
                    "id": 3695,
                    "pubMedId": 25207766,
                    "title": "Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25207766"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 55729,
        "geneSymbol": "ATF7IP",
        "terms": [
            "ATF7IP",
            "AM",
            "ATF-IP",
            "MCAF",
            "MCAF1",
            "p621"
        ]
    },
    "variant": "ATF7IP - JAK2",
    "createDate": "06/13/2016",
    "updateDate": "06/15/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 3717,
                "geneSymbol": "JAK2",
                "terms": [
                    "JAK2",
                    "JTK10",
                    "THCYT3"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 23831,
            "profileName": "ATF7IP - JAK2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}